Skip to main content
Log in

Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Monospecific antibodies were prepared by nitrocellulose blot immunoaffinity to 3 polypeptide components of the host-membrane associated B antigen of Marek's disease herpesvirus (MDV) and to its soluble A antigen. The B antigen comprised a 200 kDa dimer which is 2-mercaptoethanol (2-ME) labile, a monomer of 130 kDa and a 60 kDa protein, both of which are 2-ME resistant. Cross-immunoblotting studies showed that the anti-dimer antibody recognized the dimer protein as well as the 130 and 60 kDa components. In contrast, the anti-130 kDa antibody gave the strongest signal on blots of reducing gels indicating that the monomer is largely formed by in vitro reduction with 2-ME. All four antibodies recognized membrane antigens on chicken embryo fibroblasts infected with MDV vaccine viruses representative of the three serotypes and in addition, neutralized the homologous MDV isolate. The anti-dimer antibody was greatest, the anti-monomer antibody was the weakest and the anti-60 kDa antibody intermediate in neutralizing efficacy to all four viruses. We conclude from these studies that the B antigen presents at least two classes of neutralizing epitopes: one is discontinuous and of broad specificity on the intact dimer molecule and the other, on the 130 and 60 kDa proteins, is continuous and of lower avidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chapsal JM, Pereira L (1988) Characterization of epitopes on native and denatured forms of herpes simplex virus glycoprotein B. Virology 164: 427–434

    Google Scholar 

  2. Chubb RC, Churchill AE (1968) Precipitating antigens associated with Marek's disease. Vet Rec 83: 4–7

    Google Scholar 

  3. Coussens PM, Velicer LF (1988) Structure and complete nucleotide sequence of Marek's disease herpesvirusvirus gp57–65 gene. J Virol 62: 2373–2379

    Google Scholar 

  4. Coussens PM, Wilson MR, Camp H, Roehl H, Isfort RJ, Velicer LF (1990) Characterization of the gene encoding herpesvirus of turkeys pp 57–65: comparison to Marek's disease virus gp57–65 and herpes simplex virus glycoprotein C. Virus Genes 4: 291–308

    Google Scholar 

  5. Creighton TE (1988) Disulphide bonds and protein stability. Bioessays 8: 57–63

    Google Scholar 

  6. Davidson I, Maray T, Malkinson M, Becker Y (1986) Detection of Marek's disease virus antigens and DNA in feathers from infected chickens. J Virol Methods 13: 231–244

    Google Scholar 

  7. Davidson I, Malkinson M, Becker Y (1988) Marek's disease virus serotype-1 antigen A and B and their unglycosylated precursors detected by western blot analysis of infected cells. Virus Genes 2: 5–18

    Google Scholar 

  8. Davidson I, Weisman Y, Orgad U, Jacobson B, Perl S, Strenger C, Becker Y, Malkinson M (1988) Pathogenicity studies of Marek's disease virus isolates in Israel. Israel J Vet Med 44: 223–232

    Google Scholar 

  9. Hirai K, Nakajima K, Ikuta K, Kirisawa R, Mikami K, Kato S (1986) Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus. Arch Virol 89: 113–130

    Google Scholar 

  10. Ihara T, Kato A, Ueda S, Ishihama A, Hirai K (1989) Comparison of the sequence of the secretory glycoprotein A (gA) gene in Md5 and BC-1 strains of Marek's disease virus type 1. Virus Genes 3: 127–140

    Google Scholar 

  11. Ikuta K, Ueda S, Kato S, Hirai K (1984) Identification with monoclonal antibody of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization. J Virol 49: 1014–1017

    Google Scholar 

  12. Ikuta K, Ueda S, Kato S, Hirai K (1984) Processing of glycoprotein gB related to neutralization of Marek's disease virus of turkeys. Microbiol Immunol 28: 923–933

    Google Scholar 

  13. Ikuta K, Ueda S, Kato S, Hirai K (1983) Monoclonal antibodies reactive with the surface and secreted glycoproteins of Marek's disease virus and herpesvirus of turkeys. J Gen Virol 64: 2597–2610

    Google Scholar 

  14. Isfort RJ, Sithole I, Kung HJ, Velicer LF (1986) Molecular characterization of Marek's disease herpesvirus B antigen. J Virol 59: 411–419

    Google Scholar 

  15. Kaluza G, Pauli G (1980) The influence of intramolecular disulfide bonds on the structure and function of Semliki Forest virus membrane glycoproteins. Virology 102: 300–309

    Google Scholar 

  16. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227: 68–685

    Google Scholar 

  17. Lee LF, Kieff ED, Bachenheimer SL, Roizman B, Spear PG, Burmestar BR, Nazarian K (1971) Size and composition of Marek's disease virus deoxyribonucleic acid. J Virol 7: 289–294

    Google Scholar 

  18. Lucaks N, Theil HJ, Mettenleiter TC, Rhiza HJ (1985) Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulphide-linked glycoprotein complex. J Virol 53: 166–173

    Google Scholar 

  19. Olmsted JB (1986) Analysis of cytoskeletal structures using blot-purified monospecific antibodies. Methods Enzymol 134: 467–472

    Google Scholar 

  20. Ono K, Takashima M, Ishikawa T, Hayashi M, Yoshida I, Konobe T, Ikuta K, Nakajima K, Ueda S, Kato S, Hirai K (1984) Partial protection against Marek's disease in chickens immunized with glycoproteins gB purified from turkey-herpesvirus-infected cells by affinity chromatography coupled with monoclonal antibodies. Avian Dis 29: 533–539

    Google Scholar 

  21. Pereira L, Ali M, Kousoulas K, Huo B, Banks T (1989) Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172: 11–24

    Google Scholar 

  22. Roizman B, Meignier B, Norrild B, Wagner JL (1984) Bioengineering of herpes simplex virus variants for potential use as live vaccines. In: Chanock RM, Lerner RA (eds) Modern approaches to vaccines; molecular and chemical basis of virus virulence and immunogenicity. Cold Spring Harbor Laboratory, New York, pp 275–281

    Google Scholar 

  23. Ross LJN, Sanderson M, Scott SD, Binns MM, Doel T, Milne B (1989) Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J Gen Virol 70: 1789–1804

    Google Scholar 

  24. Sharma JM (1980) Marek's disease In: Hitchner SB, Domermuth CH, Purchase HG, Williams JE (eds) Isolation and identification of avian pathogens. American Association of Avian Pathologists, College Station, Texas, pp 91–95

    Google Scholar 

  25. Schat KA, de Boer GF, Hirai K, Lee LF, Nakajima K, Silva RF, Velicer LF (1988) A proposed nomenclature for the proteins of Marek's disease herpesvirus. In: Advances in Marek's disease research. Proceedings of the 3rd International Symposium on Marek's disease, Osaka, Japan, pp 438–443

  26. Silva RF, Lee LF (1984) Monoclonal antibody mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or turkey herpesvirus. Virology 136: 307–320

    Google Scholar 

  27. Sithole I, Coussens PM, Lee LF, Velicer LF (1988) Identification of Marek's disease herpesvirus B antigen's precursor polypeptide and the gene encoding it. In: Advances in Marek's disease research. Proceedings of the 3rd International Symposium on Marek's disease, Osaka, Japan, pp 148–155

  28. Sithole I, Lee LF, Velicer LF (1988) Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex. J Virol 62: 4270–4279

    Google Scholar 

  29. Spear PG (1985) Glycoproteins specified by herpes simplex viruses. In: Roizman B (ed) The herpesviruses, vol 3. Plenum, New York, pp 315–356

    Google Scholar 

  30. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354

    Google Scholar 

  31. van Zaane D, Brinkhof JMA, Westenbrink F, Gielkens ALJ (1982) Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology 121: 116–132

    Google Scholar 

  32. Wallach MG, Mencher D, Yarus S, Pillemer G, Halabi A, Pugash T (1989)Eimeria maxima: identification of gametocyte protein antigens. Exp Parasitol 68: 49–56

    Google Scholar 

  33. Watson RJ, Weis JH, Salstrom JS, Enquist LW (1982) Herpes simplex virus type 1 glycoprotein D gene: nucleotide sequence and expression inEscherichia coli. Science 218: 381

    Google Scholar 

  34. Witter RL (1983) Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis 27: 113–132

    Google Scholar 

  35. Wright KE, Salvato MS, Buchmeier (1989) Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology 171: 417–426

    Google Scholar 

  36. Wyn-Jones AP, Kaaden OR (1979) Induction of virus neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys. Infect Immun 25: 54–59

    Google Scholar 

  37. York JJ, Sonza S, Fahey KJ (1987) Immunogenic glycoproteins of infectious laryngotracheitis herpesvirus. Virology 161: 340–347

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davidson, I., Becker, Y. & Malkinson, M. Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes. Archives of Virology 121, 125–139 (1991). https://doi.org/10.1007/BF01316749

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01316749

Keywords

Navigation